Skip to main content

Hainan Haiyao Co., Ltd. (000566.SZ)

SHZ Healthcare Drug Manufacturers - Specialty & GenericView data quality →
24.0Poor

ValueMarkers Composite Index

Top 0%#44,714 of 44,714

DCF data not available

Piotroski
2/9
Weak
Beneish
-4.51
Low Risk
Altman
-1.33
Distress
DCF Value
-
N/A
ROIC
-42.2%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Hainan Haiyao Co., Ltd. (000566.SZ) — VMCI valuation read

000566.SZ screens at VMCI 24/100, a 26-point gap below the Healthcare sector median (50). For a mid-cap Hainan Haiyao Co., Ltd. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

000566.SZ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 000566.SZ trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.3x leaves covenant headroom, which sets the rate-cycle exposure for Hainan Haiyao Co., Ltd..

000566.SZ rose 2.5% over the trailing 7 days, with a +7.3% read on a 30-day basis.

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor medicine series, cochlear implant series, etc.; and vitamin C for injection scurvy, idiopathic methemoglobinemia, etc. The company also provides internet medical treatment and medical services. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.

CEO: Rongyi Xu2,003 employeesCNwww.haiyao.com.cn

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 000566.SZ’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.